Kenvue CEO Discusses Growth Outlook After J&J Unit Jumps 20% in Market Debut
Johnson & Johnson's consumer-health unit Kenvue made its debut on the New York Stock Exchange and jumped about 20% on Thursday. Thibaut Mongon, CEO of Kenvue, joined Cheddar News to discuss business growth goals and what lies ahead for its well-known pipeline of products, including Band-Aid, Neutrogena, Tylenol, among others.
Amazon is discontinuing its decade-old philanthropic program, AmazonSmile, which allowed customers to donate 0.5 percent of the cost of their purchase to select charities.
Volkswagen U.S. CEO Pablo Di Si joined Cheddar New to discuss record quarterly electric vehicle sales and his reaction to Tesla trimming prices on some vehicles by 20% last week. “We'll continue with our pricing strategy, we're not cutting prices on the vehicle's quality over quantity and product content,” he said.
